Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
about
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersIdentification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neuronsCatalponol enhances dopamine biosynthesis and protects against L-DOPA-induced cytotoxicity in PC12 cellsChiral capillary electrophoresis-mass spectrometry of tetrahydroisoquinoline-derived neurotoxins: observation of complex stereoisomerism2-(2-Iodo-phen-yl)-1,2,3,4-tetra-hydro-isoquinoline-1-carbonitrile.2-(4-Bromo-phen-yl)-3,4-dihydro-isoquinolin-2-ium thio-cyanate hemihydrate.2-(2-Hy-droxy-phen-yl)-3,4-dihydro-iso-quinolin-1(2H)-one2-(4-Iodo-phen-yl)-1,2,3,4-tetra-hydro-isoquinoline-1-carbonitrileNeurotoxic effects of tetrahydroisoquinolines and underlying mechanismsPositive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.Neuroendocrine regulation of prolactin secretion during late pregnancy: easing the transition into lactation.Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridineStimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway.PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated.Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.Low Vs. High Alcohol: Central Benefits Vs. Detriments.Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.Effects of drotaverine hydrochloride on viability of rat cultured cerebellar granulocytes.
P2860
Q26826093-008BA05B-F730-45A7-B05B-C141C4DAF6F8Q28469183-858A5FD3-0C08-4F3A-A6D0-C57465A90FF7Q28571383-1A4DD680-4584-43EC-8CCD-4966BE7B9170Q34930863-610FD77D-A555-494A-9929-77171B5EF81CQ35060719-18408B38-E735-425D-AFB8-E925DD813240Q35443530-C7EAF2F4-EB5F-4FD9-8CED-7A2C215A4860Q35444031-E47B606C-8A41-49BD-8EA9-19F85CD75D19Q35542412-E6761908-6EBD-4699-81C1-C80AE87595D3Q35545943-CDC293E0-132D-4B22-A5A2-3E9C8343A9DDQ36039402-1AAA93CB-88EE-4813-8C1F-816ED34A476DQ36157166-B1B4063F-AD12-49F8-A289-6D63E050AF3BQ36315569-25CE21FD-EBE0-4750-8FEB-83224FE1445DQ37886152-1B25CB7C-A623-4886-873C-D03F6C9D27EAQ38021940-A5BE26C0-9C02-4EA6-985F-5D1CDF3561E2Q39003365-D6B2913C-244E-4D4C-9A1E-65D8DA7ECEA8Q39036997-CA53E601-D567-4BE4-A6B9-480854C93EC1Q39159132-F7F21F34-A239-4058-982C-FBB672A55E26Q39609418-5CCAA371-98DC-403E-B75C-08C92599A9BAQ40566470-674CE011-DFBC-459A-AFE4-824A1468114CQ47663680-924D5AAA-3407-434E-B7D8-54C0730ABC97Q48004001-AF5B3249-05B1-455E-8FC3-560A637F3C25Q48438229-96D6D3AC-CAAC-42B3-B50B-33DA5C3106AB
P2860
Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@ast
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@en
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@nl
type
label
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@ast
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@en
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@nl
prefLabel
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@ast
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@en
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@nl
P2093
P921
P1476
Selective dopaminergic neuroto ...... s of the dopamine transporter.
@en
P2093
Alexander Storch
Andreas Hein
Hans Uwe Wolf
Johannes Schwarz
Kazuo Matsubara
Rainer Ortmann
Shigeru Ohta
Stefan Frenzel
Stefanie Ott
Yu I Hwang
P304
P356
10.1016/S0006-2952(01)00922-4
P407
P577
2002-03-01T00:00:00Z